celltrion vegzelma permission canada
Scope
Date
~
-
Aerospace & Defense
S.Korean drone exports quadruple from goal
South Korean drone exports surged to $1.11 million in 2023, exceeding the government's target by more than four times, fueled by strong demand for d...
Dec 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Vegzelma listed on US PBM preferred drug list
South Korea's Celltrion Healthcare Co. announced on Tuesday that its anti-cancer biosimilar Vegzelma (active ingredient: bevacizumab) was listed as ...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Herzuma selected as funded brand in NZ
Celltrion Healthcare Co. announced on Thursday that its biosimilar anticancer drug Herzuma (active ingredient trastuzumab) for breast and gastr...
Dec 07, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Cyron to develop multi-specific antibody new drug
South Korea’s biopharmaceutical company Celltrion Inc. announced on Wednesday that it signed a joint research agreement with domestic startup ...
Dec 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare's Remsima SC to be launched in US in 2024
Celltrion Healthcare Co. announced on Thursday that its autoimmune disease treatment Zymfentra (the US product name for Remsima SC) is set to be lau...
Nov 30, 2023 (Gmt+09:00)
-
Energy
KHNP eyes Canada's nuclear energy project with ARC, NB Power
Korea Hydro and Nuclear Power Co. (KHNP) said on Wednesday it has signed a non-binding agreement with ARC Clean Technology Canada Inc. and New Bruns...
Nov 29, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Electronics
LG Elec’s vehicle systems plants running above full capacity
LG Electronics Inc.'s automotive electronics production plants have surpassed 100% of their operating rate this year as of the end of September.Acco...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to supply Remsima to Brazil gov’t in three-year row
South Korea's Celltrion Healthcare Co. announced on Friday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for the B...
Nov 10, 2023 (Gmt+09:00)
-
Batteries
POSCO Holdings to secure lithium from oil-field brine in Canada
South Korea's POSCO Holdings Inc. announced on Wednesday it signed a memorandum of understanding (MOU) with Invest Alberta Corporation (IAC) in Seou...
Nov 08, 2023 (Gmt+09:00)
-
Earnings
Celltrion enjoys record earnings on healthy biosimilar biz
South Korean pharmaceutical giant Celltrion Inc. logged record quarterly earnings on the strong performance of its key biosimilar products while exp...
Nov 07, 2023 (Gmt+09:00)
-
Korean food
Tous Les Jours opens first store in Canada
CJ Foodville, the food subsidiary of South Korea's CJ Group, announced on Tuesday its bakery chain brand Tous Les Jours has opened its first store i...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s approved merger removes hurdle to three-way combination
South Korea’s biosimilar drugmaker Celltrion group on Monday moved one step closer to the planned combination of its three major affiliates wi...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Remsima SC
South Korea's Celltrion Inc. announced on Monday it received a new drug approval for an autoimmune disease treatment Remsima SC (active ingredient i...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare wins Remsima order in France, Italy
South Korea's Celltrion Healthcare Co. announced on Wednesday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for ho...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare to supply Yuflyma to US pharmacy chain
South Korea's Celltrion Healthcare Co. has inked a deal with the US specialty pharmacy chain CarePartners Pharmacy to supply its autoimmune disease ...
Oct 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Proxy adviser ISS backs drug giant Celltrion's merger plan
South Korean drug giant Celltrion Group has received a positive recommendation from Institutional Shareholder Services (ISS), a global leading proxy...
Oct 06, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Motor, Kia to adopt Tesla’s charging standard for EVs
Hyundai Motor Co. and Kia Corp. have joined Tesla's Supercharger network for electric vehicles (EV).The North American branches of the two South Kor...
Oct 06, 2023 (Gmt+09:00)
-
Food & Beverage
Canada's Tim Hortons to open 2nd store in Gangnam
Canada's No. 1 coffee chain Tim Hortons announced on Thursday that it plans to establish its second South Korean flagship store at the bustling Te...
Oct 05, 2023 (Gmt+09:00)
-
Carbon neutrality
Samsung Engineering partners with global firms for CCUS
South Korea's Samsung Engineering is ramping up its strategies in the carbon capture, utilization, and storage (CCUS) arena by securing partnerships...
Oct 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Pharm gets GMP certification from Japan
Celltrion Pharm Inc. announced on Wednesday that its pre-filled syringe (PFS) production facility in Cheongju, North Chungcheong Province has obtain...
Sep 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets sales approval for Yuflyma in Japan
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it has secured approval from the Japanese Ministry of Health, Labou...
Sep 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion signs largest-ever quarterly deal with global sales affiliate
Celltrion Inc., a South Korean biopharmaceutical giant, said Monday it will provide biosimilars worth 423.6 billion won ($323.6 million), its larges...
Sep 25, 2023 (Gmt+09:00)
-
Energy
US court rules in favor of Korea's nuclear reactor exports
A US district court on Monday dismissed Westinghouse Electric Corp.’s lawsuit against South Korean state-run companies to block their nuclear ...
Sep 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare to supply Yuflyma to five regional gov’ts in Italy
South Korea's Celltrion Healthcare Co. announced on Monday that it will supply its biosimilar Yuflyma (active ingredient: adalimumab) for the treatm...
Sep 18, 2023 (Gmt+09:00)
-
KOREA Investment Week 2023
Celltrion builds clinical data bank for new biosimilars
The use of data and computing is a new paradigm in the biopharmaceutical industry, reducing the new drug development time and cost, Celltrion Inc. C...
Sep 12, 2023 (Gmt+09:00)
-
Food & Beverage
Canada's coffee brand Tim Hortons to open store in Gangnam
Canada's No. 1 coffee chain Tim Hortons revealed plans on Tuesday to establish its first South Korean flagship store at the bustling intersection of...
Sep 12, 2023 (Gmt+09:00)
-
Artificial intelligence
KT, Vector Institute to cooperate for hyperscale AI
South Korea's KT Corp. announced on Wednesday that it has been in talks with Canada's Vector Institute to explore collaborative opportunities in the...
Sep 06, 2023 (Gmt+09:00)
-
Batteries
Solus aims to mass-produce copper foil in Canada from 2026
Solus Advanced Materials Co., a South Korean copper foil supplier to Tesla Inc., on Tuesday broke ground on its third overseas plant in Quebec, Cana...
Sep 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to expand new plant for drug products
South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday that it plans to enlarge its finished pharmaceuticals manufacturing facility...
Sep 05, 2023 (Gmt+09:00)